Wound Care News and Research

RSS

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Nexera Medical, Inc., today announced plans to submit to the U.S. Food and Drug Administration amended antimicrobial claims for its current 510(k) clearance for the SpectraShield 9500 Surgical N95 Respirator with embedded antimicrobial technology. The expanded antimicrobial claims will be supported by test data on the inactivation performance of certain strains of viruses.

8 Sep 2011

Covalon reports net loss of $1,207,559 for third quarter 2011

Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update. "We are very pleased that Covalon continues to make excellent progress in meeting its objectives.

29 Aug 2011

MME, WNDM sign major agreement to distribute CellerateRX

Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.

23 Aug 2011

AHRQ awards Johns Hopkins Evidence-based Practice Center $475,000 for study on effective wound care

An estimated $25 billion is spent annually on treating chronic wounds on patients in the United States. These chronic wounds deeply affect the quality of life of more than six million people who have them. The most common types of chronic skin wounds and skin ulcers are related to venous disease (conditions related to or caused by veins that become diseased or abnormal).

18 Aug 2011

Covalon to showcase latest line of innovative wound care and coating products at FIME Expo

Covalon Technologies Ltd., an advanced medical technologies company, today announced it is presenting its latest line of advanced wound care and medical coating products, including ColActive® Plus Ag from August 10th to 12th at FIME International Medical Expo.

8 Aug 2011

FDA clears Derma Sciences' MEDIHONEY Hydrogel Wound and Burn Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has received U.S. Food and Drug Administration 510(k) clearance for its patented MEDIHONEY Hydrogel Wound and Burn Dressing with Leptospermum honey.

2 Aug 2011

Kinetic Concepts second quarter total revenue increases 4% to $519.8 million

Kinetic Concepts, Inc. today reported second quarter 2011 total revenue of $519.8 million, an increase of 4% from the second quarter of 2010.

26 Jul 2011

MiMedx second quarter revenue increases 85% to $1,929,000

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the second quarter and six months ended June 30, 2011.

25 Jul 2011

Alliqua acquires global license for wound care dressings from Noble Biomaterials

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies today announced that it has acquired from Noble Biomaterials, Inc. a 10 year exclusive global license for two wound care dressings, with an additional 10 year renewal option.

21 Jul 2011

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Kinetic Concepts, Inc. today announced that its groundbreaking V.A.C.Via Negative Pressure Wound Therapy System has been granted reimbursement status and will be listed on the U.K. Drug Tariff beginning August 1, 2011.

30 Jun 2011

Exciton enters distribution agreement with Marathon Medical

Exciton Technologies Inc. today announced the Company has signed a distribution agreement with Marathon Medical, adding them to the existing Federal Supply Schedule (FSS) contract, administered by the Department of Veterans Affairs on behalf of the U.S. General Services Administration (GSA), effective July 1st.

29 Jun 2011

Derma Sciences announces $29 million financing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has closed its previously announced private placement.

27 Jun 2011

Derma Sciences to raise $29M through private placement

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has entered into definitive agreements with select institutional investors to raise gross proceeds of approximately $29 million.

20 Jun 2011

Chinese medical devices market to achieve revenues of $30.6B by 2017

The Chinese medical devices market has enjoyed rapid growth of late and is forecast to achieve revenues of $30.6 billion by 2017, according to a report released on companiesandmarkets.com.

10 Jun 2011

Systagenix introduces WOUNDCHEK system at EWMA 2011

Systagenix, the home of the Let's Heal system, attended the 2011 European Wound Management Association conference (EWMA) in Belgium and introduced the WOUNDCHEK brand; the umbrella brand name of its soon to be launched point of care tests, to an international audience of over 2,500 clinicians.

7 Jun 2011

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

The 26th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing will be held September 9-12, 2011, at the Gaylord National Hotel & Convention Center, National Harbor, MD.

7 Jun 2011

3M introduces Kind Removal Silicone Tape for patients with sensitive, at-risk skin

3M Skin and Wound Care introduces 3M Kind Removal Silicone Tape with a new, silicone-based, adhesive technology that provides an optimal balance of securement and gentleness.

7 Jun 2011

Regenesis Biomedical closes $5.3M Series C equity financing

Regenesis Biomedical, Inc., a medical technology company that markets the Provant Therapy System, announced today the closing of a $5.3 million Series C equity financing.

7 Jun 2011

Derma Sciences announces results of DSC127 Phase 2 trial in diabetic foot ulcers at 24-weeks

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.

25 May 2011

3M Skin and Wound Care introduces Tegaderm Diamond Dressing with Comfort Adhesive Technology

3M Skin and Wound Care introduces 3M Tegaderm Diamond Pattern Film Dressing, a versatile dressing solution with transparent, breathable film, preferred frame delivery system and new, Comfort Adhesive Technology.

25 May 2011

Wound Care News and Research

Nexera to submit amended claims for FDA 510(k) clearance of SpectraShield 9500 Surgical N95 Respirator

Covalon reports net loss of $1,207,559 for third quarter 2011

MME, WNDM sign major agreement to distribute CellerateRX

AHRQ awards Johns Hopkins Evidence-based Practice Center $475,000 for study on effective wound care

Covalon to showcase latest line of innovative wound care and coating products at FIME Expo

FDA clears Derma Sciences' MEDIHONEY Hydrogel Wound and Burn Dressing

Kinetic Concepts second quarter total revenue increases 4% to $519.8 million

MiMedx second quarter revenue increases 85% to $1,929,000

Alliqua acquires global license for wound care dressings from Noble Biomaterials

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Exciton enters distribution agreement with Marathon Medical

Derma Sciences announces $29 million financing

Derma Sciences to raise $29M through private placement

Chinese medical devices market to achieve revenues of $30.6B by 2017

Systagenix introduces WOUNDCHEK system at EWMA 2011

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

3M introduces Kind Removal Silicone Tape for patients with sensitive, at-risk skin

Regenesis Biomedical closes $5.3M Series C equity financing

Derma Sciences announces results of DSC127 Phase 2 trial in diabetic foot ulcers at 24-weeks

3M Skin and Wound Care introduces Tegaderm Diamond Dressing with Comfort Adhesive Technology

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News